{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T11:42:13Z","timestamp":1650454933709},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00059-014-4164-4","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T04:01:24Z","timestamp":1413950484000},"page":"814-818","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anithrombotische Therapie und Vorhofflimmern"],"prefix":"10.1007","volume":"39","author":[{"given":"U.","family":"Zeymer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,23]]},"reference":[{"key":"4164_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12181-012-0436-5","volume":"6","author":"Achenbach","year":"2012","unstructured":"Achenbach S, Zeymer U, Szardien S et al (2012) Kommentar zu den Leitlinien der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie zur Diagnostik und Therapie des akuten Koronarsyndroms ohne persitierende ST-Strecken-Hebungen. Kardiologe 6:283\u2013301","journal-title":"Kardiologe"},{"key":"4164_CR2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12181-013-0530-3","volume":"7","author":"Zeymer","year":"2013","unstructured":"Zeymer U, Kastrati A, Rassaf T et al (2013) Kommentar zu den Leitlinien der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie zur Therapie des akuten Herzinfarktes bei Patienten mit ST-Hebung. Kardiologe 7:410\u2013422","journal-title":"Kardiologe"},{"key":"4164_CR3","doi-asserted-by":"crossref","unstructured":"Windecker S, Kolh C, Alfonso F et al (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J [e-pub ahead of print]","DOI":"10.5603\/KP.2014.0224"},{"key":"4164_CR4","unstructured":"Lip GYH, Winder S, Huber K et al (2014) Management of atrial fibrillation patients presenting with acute coronary syndromes and\/or undergoing percutaneous coronary or valve interventions. Eur Heart J [e-pub ahead of print]"},{"key":"4164_CR5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","volume":"30","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Duray G, Gersh BJ, Hohnloser SH (2009) Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 30:1038\u20131045","journal-title":"Eur Heart J"},{"key":"4164_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00392-011-0357-5","volume":"101","author":"Zusman","year":"2012","unstructured":"Zusman O, Amit G, Gilutz H et al (2012) The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol 101:17\u201322","journal-title":"Clin Res Cardiol"},{"key":"4164_CR7","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719\u20132747","journal-title":"Eur Heart J"},{"key":"4164_CR8","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.ijcard.2013.03.037","volume":"168","author":"Lopes","year":"2013","unstructured":"Lopes RD, White JA, Atar D et al (2013) Incidence, treatment and outcomes of atrial fibrillation complicating non-ST segment elevation acute coronary syndromes. Int J Cardiol 168:2510\u20132517","journal-title":"Int J Cardiol"},{"key":"4164_CR9","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","volume":"360","author":"ACTIVE","year":"2009","unstructured":"ACTIVE Investigators, Connolly SJ, Pogue J et al (2009) Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360:2066\u20132078","journal-title":"N Engl J Med"},{"key":"4164_CR10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"ACTIVE","year":"2006","unstructured":"ACTIVE Writing Group of the ACTIVE Investigators1, Connolly S, Pogue J et al (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367:1903\u20131912","journal-title":"Lancet"},{"key":"4164_CR11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","volume":"347","author":"Hurlen","year":"2002","unstructured":"Hurlen M, Abdelnoor M, Smith P et al (2002) Warfarin, aspirin or both after myocardial infarction. N Engl J Med 347:969\u2013974","journal-title":"N Engl J Med"},{"key":"4164_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","volume":"360","author":"Es","year":"2002","unstructured":"Es RF van, Jonker JJ, Verheugt FW et al (2002) Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 360:109\u2013113","journal-title":"Lancet"},{"key":"4164_CR13","doi-asserted-by":"crossref","first-page":"E864","DOI":"10.1002\/ccd.25064","volume":"82","author":"Schlitt","year":"2013","unstructured":"Schlitt A, Rubboli A, Lip GY et al (2013) The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the atrial fibrillation undergoing coronary artery stenting study. Catheter Cardiovasc Interv 82:E864\u2013E870","journal-title":"Catheter Cardiovasc Interv"},{"key":"4164_CR14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4244\/EIJV8I9A163","volume":"8","author":"Pilgrim","year":"2013","unstructured":"Pilgrim T, Kalesan B, Zanchin T et al (2013) Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. EuroIntervention 8:1061\u20131071","journal-title":"EuroIntervention"},{"key":"4164_CR15","first-page":"170","volume":"25","author":"Rubboli","year":"2013","unstructured":"Rubboli A, Sciahbasi A, Briguori C et al (2013) In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry. J Invasive Cardiol 25:170\u2013176","journal-title":"J Invasive Cardiol"},{"key":"4164_CR16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH13-04-0351","volume":"110","author":"Bernard","year":"2013","unstructured":"Bernard A, Fauchier L, Pellegrin C et al (2013) Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation. Thromb Haemost 110:560\u2013568","journal-title":"Thromb Haemost"},{"key":"4164_CR17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","volume":"126","author":"Lambert","year":"2012","unstructured":"Lambert M, Olesen JB, Ruwald MH et al (2012) Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention. A nationwide cohort study. Circulation 126:1185\u20131193","journal-title":"Circulation"},{"key":"4164_CR18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"Dewilde","year":"2013","unstructured":"Dewilde WJM, Oirbans T, Verheught FWA et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomized, controlled trial. Lancet 381:1107\u20131115","journal-title":"Lancet"},{"key":"4164_CR19","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2013.02.036","volume":"61","author":"Sarafoff","year":"2013","unstructured":"Sarafoff N, Martischnig A, Wealer J et al (2013) Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. J Am Coll Cardiol 61:2060\u20132064","journal-title":"J Am Coll Cardiol"},{"key":"4164_CR20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","volume":"127","author":"Dans","year":"2013","unstructured":"Dans AL, Connolly SJ, Wallentin L et al (2013) Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation 127:634\u2013640","journal-title":"Circulation"},{"key":"4164_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","volume":"366","author":"Mega","year":"2012","unstructured":"Mega JL, Braunwald E, Wiviott SD et al; ATLAS ACS2\u2013TIMI 51 Investigators (2012) Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366:9\u201319","journal-title":"N Engl J Med"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-014-4164-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4164-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T11:02:48Z","timestamp":1650452568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-014-4164-4"}},"subtitle":["Duale oder Triple-Therapie nach akutem Koronarsyndrom und Stent?"],"short-title":[],"issued":{"date-parts":[[2014,10,23]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1007\/s00059-014-4164-4","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,23]]}}}